Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario M5G 2N2, Canada.
Semin Immunol. 2011 Aug;23(4):282-92. doi: 10.1016/j.smim.2011.04.003. Epub 2011 May 17.
Several types of regulatory T cells maintain self-tolerance and control excessive immune responses to foreign antigens. The major regulatory T subsets described over the past decade and novel function in transplantation will be covered in this review with a focus on CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells. Multiple mechanisms have been proposed to explain how Treg cells inhibit effector cells but none can completely explain the observed effects in toto. Proposed mechanisms to explain suppressive activity of Treg cells include the generation of inhibitory cytokines, induced death of effector cells by cytokine deprivation or cytolysis, local metabolic perturbation of target cells mediated by changes in extracellular nucleotide/nucleoside fluxes with alterations in intracellular signaling molecules such as cyclic AMP, and finally inhibition of dendritic cell functions. A better understanding of how Treg cells operate at the molecular level could result in novel and safer therapeutic approaches in transplantation and immune-mediated diseases.
几种类型的调节性 T 细胞可维持自身耐受并控制对外来抗原的过度免疫反应。本篇综述将涵盖过去十年中描述的主要调节性 T 细胞亚群及其在移植中的新功能,重点介绍 CD4+CD25+Foxp3+调节性 T(Treg)细胞。已经提出了多种机制来解释 Treg 细胞如何抑制效应细胞,但没有一种机制可以完全解释观察到的总体效应。解释 Treg 细胞抑制活性的机制包括产生抑制性细胞因子、通过细胞因子剥夺或细胞溶解诱导效应细胞死亡、通过改变细胞外核苷酸/核苷通量并改变细胞内信号分子(如环 AMP)来介导靶细胞的局部代谢扰动,以及最后抑制树突状细胞功能。更好地了解 Treg 细胞在分子水平上的作用可能会导致在移植和免疫介导的疾病中产生新的、更安全的治疗方法。